NCT05611307Recruiting
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant
Source: ClinicalTrials.gov · Last updated 30 Oct 2026
Brief summary (registry, in English)
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 21 Oct 2022
- Start date
- 11 Oct 2022
- Primary completion date
- Jul 2027
- Lead sponsor
- Indiana University
- Diseases
- Coronary artery disease
- NCT number
- NCT05611307
What you commit to
- Study type: Observational
- Planned participants: 150
- From 11 Oct 2022 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior known myocardial infarction (MI), atherosclerotic cardiovascular disease (ASCVD)
Other illness
- Allergy to iodinated contrast
- Antecedent chemotherapy for another primary cancer.
Lab values
- Significant renal disease (GFR\<40)
Who the study is looking for
- Patients \>18 years of age
- Patients will be recruited only if cancer-free at clinical evaluation time.
- For the cases a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies (CBCT group, Arm 2)
- For the cases with a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies and underwent BMT for relapsed refractory disease (CBCT \& BMT group, Arm 3).
- For the comparison cohort, biopsy-proven TC patients who had surgery for or surveillance of their testicular cancer and never received CBCTCBCT or BMT (surgical/surveillance, Arm 1)
Age in the registry: 18 years to 99 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indiana University Coordinator of this site? Confirm its status | Indianapolis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.